Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_assertion type Assertion NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_head.
- NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_assertion wasGeneratedBy ECO_0000203 NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_provenance.
- NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_assertion wasDerivedFrom befree-20150227 NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_provenance.
- NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_assertion SIO_000772 20830300 NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_provenance.
- NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_assertion evidence source_evidence_literature NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_provenance.
- NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_assertion description "[Administration of a Rac GTPase inhibitor (NSC23766) 15 min before cerebral ischemia significantly attenuated NADPH oxidase activation and O(2)(-) production at 3 h after stroke as compared to vehicle-treated controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352030.RA_bBbcOsWd3aKG7W3_ZE8JotgoySaJ84asvMW_4vVYLE130_provenance.